Model prediction of treatment planning for dose-fractionated radioimmunotherapy.


BACKGROUND Clinical trials of radioimmunotherapy (RIT) often use dose fractionation to reduce marrow toxicity. The dosing scheme can be optimized if marrow and tumor cell kinetics following radiation exposure are known. METHODS A mathematic model of tumor clonogenic cell kinetics was combined with a previously reported marrow cell kinetics model that… (More)